Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - sitagliptin hydrochloride monohydrate, quantity: 27.25 mg (equivalent: sitagliptin, qty 25 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; povidone; calcium hydrogen phosphate dihydrate; sodium stearylfumarate; croscarmellose sodium; magnesium stearate; titanium dioxide; purified talc; iron oxide red; polyvinyl alcohol; macrogol 3350; iron oxide black - sitaglo is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus as:,- monotherapy when metformin is considered inappropriate due to intolerance; or,- in combination with other anti-hyperglycaemic agents, including insulin,[see 5.1 pharmacodynamic properties, clinical trials, 4.5 interactions with other medicines and other forms of interactions for available data on different add-on combination therapies].

Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - sitagliptin hydrochloride monohydrate, quantity: 27.25 mg (equivalent: sitagliptin, qty 25 mg) - tablet, film coated - excipient ingredients: magnesium stearate; sodium stearylfumarate; povidone; calcium hydrogen phosphate dihydrate; croscarmellose sodium; microcrystalline cellulose; titanium dioxide; purified talc; iron oxide red; polyvinyl alcohol; macrogol 3350; iron oxide black - sitaglo is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus as:,- monotherapy when metformin is considered inappropriate due to intolerance; or,- in combination with other anti-hyperglycaemic agents, including insulin,[see 5.1 pharmacodynamic properties, clinical trials, 4.5 interactions with other medicines and other forms of interactions for available data on different add-on combination therapies].

Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - sitagliptin hydrochloride monohydrate, quantity: 109 mg (equivalent: sitagliptin, qty 100 mg) - tablet, film coated - excipient ingredients: calcium hydrogen phosphate dihydrate; microcrystalline cellulose; magnesium stearate; croscarmellose sodium; povidone; sodium stearylfumarate; titanium dioxide; purified talc; iron oxide yellow; iron oxide red; polyvinyl alcohol; macrogol 3350 - sitaglo is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus as:,- monotherapy when metformin is considered inappropriate due to intolerance; or,- in combination with other anti-hyperglycaemic agents, including insulin,[see 5.1 pharmacodynamic properties, clinical trials, 4.5 interactions with other medicines and other forms of interactions for available data on different add-on combination therapies].

Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - sitagliptin hydrochloride monohydrate, quantity: 54.5 mg (equivalent: sitagliptin, qty 50 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; magnesium stearate; povidone; calcium hydrogen phosphate dihydrate; sodium stearylfumarate; croscarmellose sodium; titanium dioxide; purified talc; iron oxide yellow; iron oxide red; polyvinyl alcohol; macrogol 3350 - sitaglo is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus as:,- monotherapy when metformin is considered inappropriate due to intolerance; or,- in combination with other anti-hyperglycaemic agents, including insulin,[see 5.1 pharmacodynamic properties, clinical trials, 4.5 interactions with other medicines and other forms of interactions for available data on different add-on combination therapies].

Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - sitagliptin hydrochloride monohydrate, quantity: 54.5 mg (equivalent: sitagliptin, qty 50 mg) - tablet, film coated - excipient ingredients: sodium stearylfumarate; calcium hydrogen phosphate dihydrate; croscarmellose sodium; magnesium stearate; povidone; microcrystalline cellulose; titanium dioxide; purified talc; iron oxide yellow; iron oxide red; polyvinyl alcohol; macrogol 3350 - sitaglo is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus as:,- monotherapy when metformin is considered inappropriate due to intolerance; or,- in combination with other anti-hyperglycaemic agents, including insulin,[see 5.1 pharmacodynamic properties, clinical trials, 4.5 interactions with other medicines and other forms of interactions for available data on different add-on combination therapies].

Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - sitagliptin hydrochloride monohydrate, quantity: 109 mg (equivalent: sitagliptin, qty 100 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; magnesium stearate; sodium stearylfumarate; povidone; calcium hydrogen phosphate dihydrate; croscarmellose sodium; titanium dioxide; purified talc; iron oxide yellow; iron oxide red; polyvinyl alcohol; macrogol 3350 - sitaglo is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus as:,- monotherapy when metformin is considered inappropriate due to intolerance; or,- in combination with other anti-hyperglycaemic agents, including insulin,[see 5.1 pharmacodynamic properties, clinical trials, 4.5 interactions with other medicines and other forms of interactions for available data on different add-on combination therapies].

United States - English - NLM (National Library of Medicine)

allermed laboratories, inc. - trichophyton mentagrophytes (unii: 199i7j3jiv) (trichophyton mentagrophytes - unii:199i7j3jiv), trichophyton rubrum (unii: 2zau32517n) (trichophyton rubrum - unii:2zau32517n) - trichophyton mentagrophytes 1 g in 1000 ml - intradermal skin tests with trichophyton extract are indicated for use in persons who are suspected of having type i hypersensitivity (i.e. allergy) to the fungus. conditions under which the administration of allergenic extract may be contraindicated, depending upon individual circumstances, include: extreme sensitivity to an allergen - determined from the allergic history, or from previous anaphylaxis following skin testing or subcutaneous injection; myocardial infarction - patients who have experienced a recent myocardial infarction may be less able to tolerate the life-threatening effects of a serious adverse reaction. asthma - patients with highly unstable asthma are at greater risk of fatal reactions from skin tests than are patients without asthma, especially during seasonal exacerbations of the disease. also, the combination of unstable asthma and treatment with b-adrenergic blockers appears to increase this risk5 . allergenic extract should be temporarily withheld from patients if any of the followin

New Zealand - English - Medsafe (Medicines Safety Authority)

ebos group ltd - allergen extracts 100 pnu/ml (trichophyton mentagrophytes, pyridine extracted, alum precip); allergen extracts 1000 pnu/ml (trichophyton mentagrophytes, pyridine extracted, alum precip); allergen extracts 10000 pnu/ml (trichophyton mentagrophytes, pyridine extracted, alum precip) - suspension for injection - active: allergen extracts 100 pnu/ml (trichophyton mentagrophytes, pyridine extracted, alum precip) excipient: aluminium hydroxide phenol sodium chloride water for injection active: allergen extracts 1000 pnu/ml (trichophyton mentagrophytes, pyridine extracted, alum precip) excipient: aluminium hydroxide phenol sodium chloride water for injection active: allergen extracts 10000 pnu/ml (trichophyton mentagrophytes, pyridine extracted, alum precip) excipient: aluminium hydroxide phenol sodium chloride water for injection

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

inmunotek - tricophyton mentagrophytes allergen extract - solution for skin-prick test

Nigeria - English - NAFDAC (National Agency for Food and Drugs Administration and Control)

vitamins & minerals